Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Laser treatment increases hair density and thickness safely in women with hair loss.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Melatonin may help treat PCOS symptoms in rats.

Ephrins slow down skin and hair follicle cell growth.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Early onset hair loss linked to genetics and androgen levels.

The arrector pili muscle might play a role in hair loss and needs more research to understand its impact.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.